首页> 外文期刊>Frontiers in Pharmacology >Patient Participation and the Use of Ehealth Tools for Pharmacoviligance
【24h】

Patient Participation and the Use of Ehealth Tools for Pharmacoviligance

机译:患者参与和使用Ehealth工具进行药物警戒

获取原文
           

摘要

In recent years, pharmacovigilance has undergone some major changes. First, the patient’s active role in identifying and describing adverse drug reactions (ADRs) has gained recognition. Second, pharmacovigilance has increasingly incorporated information and communications technology (ICT). Patients can now upload their own reports of ADRs online. Data on intensive medication monitoring are now collected via the Internet and smartphones. Worldwide collection of AEs using smart phones might become the leading technique in Low and Middle Income Countries where broad mobile phone service can be managed cheaper than Internet communication. At the same time, researchers are exploring the potential for data sharing via online forums and Internet search engines. In particular we synthetize the Pros and cons of the various methods for gathering pharmacovigilance data (i.e., Web-based spontaneous reporting of adverse drug reactions; Intensive drug monitoring studies; Analysis of online forum postings; Use of mobile phone systems to monitor drug effects). This article describes these advances and highlights their respective contributions.
机译:近年来,药物警戒发生了一些重大变化。首先,患者在识别和描述药物不良反应(ADR)中的积极作用已获得认可。第二,药物警戒越来越多地纳入信息和通信技术(ICT)。现在,患者可以在线上传自己的ADR报告。现在,可以通过Internet和智能手机收集有关强化药物监控的数据。在低收入和中等收入国家,使用智能手机在全球范围内收集AE可能成为领先的技术,在这些国家中,广泛的移动电话服务可以比互联网通信便宜地管理。同时,研究人员正在探索通过在线论坛和Internet搜索引擎进行数据共享的潜力。特别是,我们综合了收集药物警戒性数据的各种方法的优缺点(例如,基于Web的药物不良反应的自发报告;密集的药物监测研究;在线论坛帖子分析;使用移动电话系统监测药物作用) 。本文介绍了这些进展并突出了它们各自的贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号